表紙
市場調査レポート

世界の癌診断検査市場における機会

Cancer Diagnostics 2016-2020: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

発行 Venture Planning Group 商品コード 282126
出版日 ページ情報 英文 1200 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。

Local License: 同一事業所内

Back to Top
世界の癌診断検査市場における機会 Cancer Diagnostics 2016-2020: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
出版日: ページ情報: 英文 1200 Pages
概要

当レポートでは、世界の癌診断検査市場における今後5年間のビジネス機会について調査分析し、主要7ヶ国(米国、欧州5ヶ国、日本)の主要動向を検証するほか、現在/新興の診断検査、様々な診断技術の潜在的用途、主な腫瘍マーカーの売上予測(国別、市場セグメント別)、主要企業のプロファイル、主要サプライヤーの戦略的プロファイルなどを提供して、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 世界市場の概要

  • 市場概要
  • 市場構造
  • 市場規模、成長率

第3章 主な製品開発の機会

  • 試薬キットと検査システム/パネル
  • 機器
  • コンピューター、ソフトウェア、オートメーション
  • 補助製品

第4章 分散型検査製品の設計基準

第5章 代替的な市場浸透戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 流通戦略

第6章 潜在的な市場参入障壁とリスク

  • 市場の成熟度
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

第7章 世界の市場と技術の概要

  • 癌の統計と病因
    • 乳癌
    • 肺癌
    • 結腸・直腸癌
    • 前立腺癌
    • 胃癌
    • 白血病
    • リンパ腫
    • 口腔癌
    • 皮膚癌
    • 子宮癌
    • 卵巣癌
    • 膀胱癌
  • 現在/新興の癌診断検査
    • イントロダクション
    • 腫瘍マーカーの分類
    • ACTH
    • アルファフェトプロテイン(AFP)
    • β2ミクログロブリン
    • CA 15-3/27.29
    • CA 19-9
    • CA-125
    • カルシトニン
    • 癌胎児性抗原(CEA)
    • エストロゲン・プロゲステロン受容体
    • フェリチン
    • ガストリン
    • ヒト絨毛性ゴナドトロピン(HCG)
    • インスリン
    • NSE
    • 潜血
    • パップスメア/HPV
    • 前立腺酸性フォスファターゼ(PAP)
    • 前立腺特異抗原(PSA)
    • 扁平上皮癌関連抗原(SCC)
    • T・Bリンパ球
    • TdT
    • サイログロブリン
    • 組織ポリペプチド抗原(TPA)
    • 生化学腫瘍マーカー
    • 腫瘍遺伝子
    • ポリペプチド増殖因子
    • 異所性ホルモン
    • コロニー刺激因子
    • リンフォカイン
    • 免疫組織化学染色
    • 新興の腫瘍マーカー
  • 診断装置のレビューと市場ニーズ
  • 現在/新興の技術
    • モノクローナル/ポリクローナル抗体
    • 免疫測定法
    • 分子診断
    • 染色体分析
    • 人工知能
    • フローサイトメトリー
    • 二次元ゲル電気泳動(2-DGE)
    • バイオセンサー
    • 競合/補完技術
  • 個人向け検査

第8章 フランス

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第9章 ドイツ

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第10章 イタリア

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第11章 日本

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第12章 スペイン

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第13章 英国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第14章 米国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第15章 競合企業プロファイル

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Kreatech
  • 協和メデックス
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • Nuvelo
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • 東ソー
  • Vermillion/Correlogic Systems
  • 和光純薬工業
  • Wallac/PE
  • Zila

第16章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCA18446

The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

This new report from VPGMarketResearch.com is based on a new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Worldwide Market Overview

- Five-year test volume and sales projections by country.

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

- Estimated universe of laboratories performing cancer diagnostic testing by country.

- Cancer statistics, etiology and recent developments in the U.S., Europe, and Asia.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes Biochemical Markers Growth Factors Colony Stimulating Factors Hormones Immunohistochemical Stains Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product suppliers by individual test and country.

- Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:

     º  Hospitals      º  Commercial/Private Laboratories      º  Physician Offices/Group Practices      º  Cancer Clinics      º  Ambulatory Care Centers

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

- Assessment of latest technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - AdnaGen    - Agilent Technologies    - Applied Gene Technologies    - Arca BioPharma    - Beckman Coulter/Danaher    - Becton Dickinson    - Biomedical Diagnostics/Theradiag    - bioMerieux    - Bio-Rad    - CellSearch    - Cepheid    - Correlogic Systems/Vermillion    - Decode Genetics    - Diadexus    - Diagnocure    - DiaSorin    - Eiken Chemical    - Elitech Group    - Enterix/Clinical Genomics    - Enzo Biochem    - Epigenomics    - Exact Sciences    - Fujirebio    - Guided Therapeutics    - Hologic/Gen-Probe    - Kreatech/Leica    - Kyowa Medex    - Mackay Life Sciences    - Myriad Genetics    - OncoLab    - Ortho-Clinical Diagnostics    - Panacea Pharmaceuticals    - Polartechnics    - Polymedco    - PreMD    - Qiagen    - Quest Diagnostics    - Radient Pharmaceuticals    - Roche    - Scienion    - Sequenom    - Siemens Healthcare    - Takara Bio    - Targeted Diagnostics & Therapeutics    - Thermo Fisher    - Tosoh    - Veridex    - Wako Pure Chemicals    - Wallac/PE    - Zilla

Contains 1,200 pages and 450 tables

Table of Contents

I. Introduction

II. Worldwide Market Overview

  • 1. Market Overview
  • 2. Worldwide Market Structure
  • 3. Worldwide Market Size and Growth

III. Major Product Development Opportunities

  • A. Reagent Kits and Test Systems/Panels
  • B. Instrumentation
  • C. Computers, Software and Automation
  • D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation Factor

VI. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VII. Worldwide Market and Technology Overview

  • A. Cancer Statistics and Etiology
    • 1. Breast Cancer
    • 2. Lung Cancer
    • 3. Colon and Rectum Cancer
    • 4. Prostate Cancer
    • 5. Stomach Cancer
    • 6. Leukemia
    • 7. Lymphoma
    • 8. Oral Cancer
    • 9. Skin Cancer
    • 10. Uterine Cancer
    • 11. Ovarian Cancer
    • 12. Bladder Cancer
  • B. Major Current And Emerging Cancer Diagnostic Tests
    • 1. Introduction
    • 2. Tumor Marker Classification
    • 3. ACTH
    • 4. Alpha-Fetoprotein (AFP)
    • 5. Beta-2 Microglobulin
    • 6. CA 15-3/27.29
    • 7. CA 19-9
    • 8. CA-125
    • 9. Calcitonin
    • 10. Carcinoembrionic Antigen (CEA)
    • 11. Estrogen and Progesterone Receptors
    • 12. Ferritin
    • 13. Gastrin
    • 14. Human Chorionic Gonadotropin (HCG)
    • 15. Insulin
    • 16. NSE
    • 17. Occult Blood
    • 18. PAP Smear/HPV
    • 19. Prostatic Acid Phosphatase (PAP)
    • 20. Prostate-Specific Antigen (PSA)
    • 21. Squamous Cell Carcinoma Antigen (SCC)
    • 22. T and B Lymphocytes
    • 23. TdT
    • 24. Thyroglobulin
    • 25. Tissue Polypeptide Antigen (TPA)
    • 26. Biochemical Tumor Markers
      • ADA
      • B-Protein
      • PNP
      • 5'-Nucleotidase
    • 27. Oncogenes
      • Abl/abl-bcr
      • AIB1
      • BCL-2
      • BRCA1
      • CD44
      • C-fos
      • C-myb
      • C-myc
      • CYP-17
      • Erb-B
      • HPC1
      • N-myc
      • P40
      • P51
      • P53
      • PIK3CA
      • PTI-1
      • Ras
      • Reg
      • Sis
      • Src
    • 28. Polypeptide Growth Factors
      • Basic Fibroblast Growth Factor
      • Beta-TGF
      • Cachectin (TNT)
      • Calmodulin
      • ECFR
      • Nerve Growth Factor (NGF)
      • Epidermal Growth Factor (EGF)
      • Ornithine Decarboxylase
      • Transferrin
      • Transforming Growth Factor-Alpha
    • 29. Ectopic Hormones
    • 30. Colony Stimulating Factors
    • 31. Lymphokines
      • Alpha-Interferon
      • B Cell Growth Factors
      • B Cell Growth Factor (BCGF)
      • Gamma-Interferon
      • Interleukin-1 (IL-1)
      • Macrophage Activating Factor
    • 32. Immunohistochemical Stains
    • 33. Emerging Tumor Markers
      • N-Acetylglucosamine
      • Actin
      • Alpha-Actin
      • Antineuronal Antibodies
      • 7B2
      • B72.3
      • Bax
      • BCD-F9
      • BLCA-4
      • Blood Group Antigens A,B,H
      • CA 50
      • CA 72-4/TAG-72
      • CA 195
      • CA-242
      • CA-549
      • CAM 26
      • CAR-3
      • Cathepsin-D
      • Chromogranin A and B
      • Cluster 1 Antigen
      • Cluster-5/5A Antigen
      • CTA
      • CU18
      • DR-70
      • DU-PAN-2
      • Endometrial Bleeding Associated Factor
      • Endostatin
      • Epithelial Membrane Antigen
      • Feulgen Hydrolysis
      • Fibronectin
      • FSH
      • (1->3)-L-fucosyltransferase
      • Gastrin-Releasing Peptide (GRP)
      • GDCFP-15
      • Glucagon
      • Glycoamines
      • H23
      • Her-2
      • Human Carcinoma Antigen
      • HPA
      • HSP27
      • Intermediate Filaments
      • Cytokeratins/CK18/Cyfra 21-1
      • Desmin
      • Gliofibrillary Acid Protein
      • Neurofilaments
      • Vimentin
      • KA 93
      • Kinases
      • KP16D3
      • LAI
      • Leukocyte Common Antigen
      • Lewis Antigens
      • Lysophosphatidic Acid (LPA)
      • Ma 695/Ma 552
      • MABDF3
      • MAG
      • ME1
      • Minactivin
      • MN/CA9
      • MSA
      • Mucin Cancer Antigen (MCA)
      • Multiple Tumor Suppressor 1
      • Myosin
      • NEA-130
      • NMP22
      • OA-519
      • Opiod Peptides
      • P-glycoprotein
      • Pancreatic Oncofetal Antigen (POA)
      • Placental Lactogen
      • PR92
      • Proliferative Index, Ki-67
      • Px
      • RB Inactivation/Deletion
      • Ret
      • SCCL 175
      • Selectin
      • Sialic Acid
      • Sialyl SSEA-1/SLX
      • SN10
      • Somatostatin
      • TA-90
      • TABA
      • Tachykinin
      • TAG 12
      • TPS
      • Troponin
      • Tubulin
      • VCAM
      • VEGF
      • Villen

C. Instrumentation Review And Market Needs

D. Current and Emerging Technologies

  • 1. Monoclonal and Polyclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Radioimmunoassay (RIA)
    • c. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Immunofiltration
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • d. Fluorescent Immunoassays
    • e. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • f. Latex Agglutination
    • g. Immunoprecipitation
    • h. Affinity Chromatographu
    • e. Liposome Flow-Injection Immunoassay
  • 3. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
  • 4. Chromosome Analysis
    • a. Chronic Myelogenous Leukemia (CML)
    • b. Acute Myeloid Leukemia (AML)
    • c. Acute Lymphoblastic Leukemia (ALL)
    • d. Malignant Lymphomas Lymphoid Malignancies
    • e. Chronic Lymphocytic Leukemia (CLL)
    • f. Solid Cancers
    • g. Chromosomal Translocation and Oncogenes
  • 5. Artificial Intelligence
  • 6. Flow Cytometry
  • 7. Two Dimensional Gel Electrophoresis (2-DGE)
  • 8. Biosensors
  • 9. Competing/Complementing Technologies
    • a. CT
    • b. MRI
    • c. NMR
    • d. PET
    • e. Photonics Spectroscopy

E. Personal Testing

VIII. France

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales And Market Shares

IX. Germany

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales And Market Shares

X. Italy

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales And Market Shares

XI. Japan

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales And Market Shares

XII. Spain

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales And Market Shares

XIII. U.K.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales And Market Shares

XIV. U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales And Market Shares

XV. Competitive Profiles

  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

XVI. Appendixes: Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications

Appendix II: Assumed Currency Exchange Rates

List of Tables

  • Tumor Marker Classification Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
  • Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
  • France, Estimated Cancer Death Rates Per 100,000 Population
  • France, Laboratories Performing Tumor Marker Tests by Market Segment
  • France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • France, Total Tumor Marker Test Volume Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Test Volume Forecast
  • France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • France, Commercial/Private Laboratories Marker Test Volume Forecast
  • France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Sales Forecast by Test
  • France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
  • France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
  • France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
  • France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Total Tumor Marker Sales By Major Suppliers
  • France, AFP Testing Market Diagnostics Sales by Major Supplier
  • France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • France, CEA Testing Market Diagnostics Sales by Major Supplier
  • France, NSE Testing Market Diagnostics Sales by Major Supplier
  • France, PAP Testing Market Diagnostics Sales by Major Supplier
  • France, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
  • Germany, Estimated Cancer Death Rates Per 100,000 Population
  • Germany, Laboratories Performing Tumor Marker Tests by Market Segment
  • Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Germany, Total Tumor Marker Test Volume Forecast by Market Segment
  • Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
  • Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • Germany, Total Tumor Marker Sales Forecast by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Calcitonin Test Volume And Diagnostic Sales Forecast by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Total Tumor Marker Sales By Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estimated Cancer Death Rates Per 100,000 Population
  • Italy, Laboratories Performing Tumor Marker Tests by Market Segment
  • Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Italy, Total Tumor Marker Test Volume Forecast by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
  • Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Total Tumor Marker Test Market Forecast by Market Segment
  • Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
  • Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Total Tumor Markers Sales by Major Suppliers
  • Italy, AFP Testing Market Diagnostics Sales by Major Supplier
  • Italy, CEA Testing Market Diagnostics Sales by Major Supplier
  • Italy, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Japan, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Japan, Estimated Cancer Death Rates Per 100,000 Population
  • Japan, Laboratories Performing Tumor Marker Tests by Market Segment
  • Japan, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Japan, Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
  • Japan, Total Tumor Marker Testing Volume Forecast by Market Segment
  • Japan, All Market Segments Major Tumor Marker Test Volume Forecast
  • Japan, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • Japan, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Japan, Total Tumor Marker Sales Forecast by Market Segment
  • Japan, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Japan, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Japan, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Japan, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Japan, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, TPA, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan, Total Tumor Marker Sales by Major Suppliers
  • Japan, AFP Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
  • Japan, PAP Testing Market Diagnostics Sales by Major Supplier
  • Japan, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales
  • Forecast by Market Segment Spain, Estimated Cancer Death Rates Per 100,000 Population
  • Spain, Laboratories Performing Tumor Marker Tests by Market Segment
  • Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Spain, Total Tumor Marker Test Volume Forecast by Market Segment
  • Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
  • Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Spain, Total Tumor Marker Sales Forecast by Market Segment
  • Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
  • Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, S-100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment
  • Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Total Tumor Marker Sales by Major Suppliers
  • Spain, AFP Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CEA Testing Market Diagnostics Sales by Major Supplier
  • Spain, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • U.K., Estimated Cancer Death Rates Per 100,000 Population
  • U.K., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.K., Total Tumor Marker Sales Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
  • U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
  • U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Total Tumor Marker Sales and Market Shares Forecast
  • U.K., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.K., PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.S., Total Tumor Marker Test Volume and Sales Forecast By Market Segment
  • U.S., Estimated New Cancer Cases and Deaths
  • U.S., Estimated Cancer Death Rates Per 100,000 Population
  • U.S., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.S., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.S., Commercial/Private Laboratories Performing Tumor Marker Tests By Annual Test Volume
  • U.S., Physician Office Laboratories Performing Tumor Marker Tests By Practice Size
  • U.S., Total Tumor Marker Test Volume Forecast by Market Segment
  • U.S., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.S., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.S., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.S., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S., Cancer Clinics Major Tumor Marker Test Volume Forecast by Test
  • U.S., Total Tumor Marker Sales Forecast by Market Segment
  • U.S., All Market Segment Major Tumor Marker Sales Forecast by Test
  • U.S., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.S., Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • U.S., Cancer Clinics Major Tumor Marker Sales Forecast by Test
  • U.S., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., CEA Test Volume and Diagnostics Sales by Market Segment
  • U.S., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Colon-specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Cytokeratins Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Estrogen Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Interferons Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Interleukins Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Occult Blood Test Volume And Diagnostics Sales Forecast by Market Segment
  • U.S., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., Total Tumor Marker Sales By Major Supplier
  • U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
  • U.S., AFP Testing Market Diagnostics Sales by Major Supplier
  • U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
  • U.S., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
  • U.S., HCG Testing Market Diagnostics Sales by Major Supplier
  • U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
  • U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
  • U.S., PAP Testing Market Diagnostics Sales by Major Supplier
  • U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
  • U.S., PSA Testing Market Diagnostics Sales by Major Supplier
Back to Top